487 related articles for article (PubMed ID: 8606645)
1. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis.
Johansson JO; Oscarsson J; Bjarnason R; Bengtsson BA
Metabolism; 1996 Mar; 45(3):362-9. PubMed ID: 8606645
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
3. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity.
Oscarsson J; Ottosson M; Johansson JO; Wiklund O; Mårin P; Björntorp P; Bengtsson BA
Metabolism; 1996 Mar; 45(3):370-7. PubMed ID: 8606646
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults.
Laursen T; Gravholt CH; Heickendorff L; Drustrup J; Kappelgaard AM; Jørgensen JO; Christiansen JS
J Clin Endocrinol Metab; 2001 Mar; 86(3):1222-8. PubMed ID: 11238512
[TBL] [Abstract][Full Text] [Related]
5. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults.
Aimaretti G; Colao A; Corneli G; Pivonello R; MacCario M; Morrison K; Pflaum CD; Strasburger CJ; Lombardi G; Ghigo E
Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH) replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections.
Johansson JO; Wirén L; Oscarsson J; Bengtsson BA; Johannsson G
Growth Horm IGF Res; 2003 Dec; 13(6):306-15. PubMed ID: 14624763
[TBL] [Abstract][Full Text] [Related]
7. Continuous s.c. infusion rather than twice-daily injections of IGF-I more effectively increases serum IGF binding protein-3 in female monkeys.
Wilson ME; Lackey SL
Eur J Endocrinol; 1999 Sep; 141(3):303-12. PubMed ID: 10474130
[TBL] [Abstract][Full Text] [Related]
8. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.
Bülow B; Erfurth EM
Clin Endocrinol (Oxf); 1999 Jan; 50(1):45-55. PubMed ID: 10341855
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
Laursen T; Jørgensen JO; Christiansen JS
Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability and bioactivity of intravenous vs subcutaneous infusion of growth hormone in GH-deficient patients.
Laursen T; Møller J; Jørgensen JO; Orskov H; Christiansen JS
Clin Endocrinol (Oxf); 1996 Sep; 45(3):333-9. PubMed ID: 8949572
[TBL] [Abstract][Full Text] [Related]
11. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
Gargosky SE; Tapanainen P; Rosenfeld RG
Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
[TBL] [Abstract][Full Text] [Related]
13. Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults.
Oscarsson J; Johannsson G; Johansson JO; Lundberg PA; Lindstedt G; Bengtsson BA
Clin Endocrinol (Oxf); 1997 Jan; 46(1):63-8. PubMed ID: 9059559
[TBL] [Abstract][Full Text] [Related]
14. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
Vittone J; Blackman MR; Busby-Whitehead J; Tsiao C; Stewart KJ; Tobin J; Stevens T; Bellantoni MF; Rogers MA; Baumann G; Roth J; Harman SM; Spencer RG
Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
[TBL] [Abstract][Full Text] [Related]
15. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I and growth hormone have different effects on serum lipoproteins and secretion of lipoproteins from cultured rat hepatocytes.
Sjöberg A; Oscarsson J; Olofsson SO; Edén S
Endocrinology; 1994 Oct; 135(4):1415-21. PubMed ID: 7925103
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of free insulin-like growth factor-I measurement on the diagnosis and follow-up treatment of growth hormone-deficient adult patients.
Musolino NR; Da Cunha Neto MB; Marino Júnior R; Giannella-Neto D; Bronstein MD
Clin Endocrinol (Oxf); 1999 Apr; 50(4):441-9. PubMed ID: 10468902
[TBL] [Abstract][Full Text] [Related]
18. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
Yuen KC; Dunger DB
Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and bioactivity of three different doses of nasal growth hormone (GH) administered to GH-deficient patients: comparison with intravenous and subcutaneous administration.
Laursen T; Grandjean B; Jørgensen JO; Christiansen JS
Eur J Endocrinol; 1996 Sep; 135(3):309-15. PubMed ID: 8890721
[TBL] [Abstract][Full Text] [Related]
20. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
Maccario M; Aimaretti G; Grottoli S; Gauna C; Tassone F; Corneli G; Rossetto R; Wu Z; Strasburger CJ; Ghigo E
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
